New England Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$992K Sell
9,482
-5,493
-37% -$579K 0.35% 62
2014
Q3
$1.6M Sell
14,975
-288
-2% -$29.9K 0.56% 34
2014
Q2
$1.6M Sell
15,263
-622
-4% -$62.9K 0.55% 32
2014
Q1
$1.56M Sell
15,885
-196
-1% -$18.2K 0.6% 38
2013
Q4
$1.47M Buy
16,081
+948
+6% +$87.4K 0.61% 33
2013
Q3
$1.31M Buy
15,133
+2,056
+16% +$184K 0.66% 30
2013
Q2
$1.12M Buy
+13,077
New +$1.11M 0.75% 27

Other funds holding JNJ

New England Securities's JNJ Position: Q4 2014 in Review

New England Securities reduced its Johnson & Johnson (JNJ) stake by 37% in Q4 2014, selling an estimated $579K and leaving 9,482 shares worth $992K. The position accounts for 0.35% of the portfolio, ranked #62.

New England Securities first reported a position in JNJ in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.6M in Q2 2014. 2,119 funds tracked by Wall St. Rank hold JNJ as of Q4 2014.

  • New England Securities held 9,482 shares of Johnson & Johnson worth $992K as of Q4 2014.
  • New England Securities sold 5,493 Johnson & Johnson shares in Q4 2014, an estimated $579K.
  • Johnson & Johnson made up 0.35% of New England Securities's portfolio in Q4 2014, its #62 holding.
  • New England Securities first reported a position in Johnson & Johnson in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Johnson & Johnson position peaked at $1.6M in Q2 2014.
  • 2,119 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.